Ligand validation:2BY0

GLC: alpha-D-glucopyranose

GLC is a Ligand Of Interest in 2BY0 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2BY0_GLC_A_1605	50%	28%	0.102	0.852	0.73	2.12	-	4	1	1	100%	1
2BY3_GLC_A_1606	63%	5%	0.098	0.893	1.1	4.14	2	9	1	1	100%	0.87
2BXZ_GLC_A_1606	63%	49%	0.092	0.886	0.71	1.24	-	2	0	0	100%	0.8
2BY2_GLC_A_1606	61%	12%	0.107	0.894	0.9	3.1	-	8	0	0	100%	0.87
2BY1_GLC_A_1605	42%	27%	0.108	0.825	0.74	2.18	-	6	1	1	100%	1
2BHY_GLC_A_1614	26%	27%	0.172	0.812	0.56	2.33	-	3	0	1	100%	0.88
5O59_GLC_A_608	100%	61%	0.025	0.992	0.81	0.69	-	-	0	0	92%	1
8R4G_GLC_C_1001	100%	39%	0.042	0.991	0.8	1.57	1	3	1	0	100%	1
3W7S_GLC_A_1002	99%	64%	0.046	0.974	0.56	0.83	-	-	0	0	100%	1
5MTT_GLC_A_407	98%	66%	0.053	0.993	0.38	0.92	-	-	0	0	92%	0.64
8R53_GLC_A_901	98%	61%	0.047	0.969	0.78	0.72	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.